Policy

Amazon’s $3.9 billion reach into health care is hard to stop

Andy Jassy’s got 99 antitrust problems, but One Medical probably won’t be one.

An illuminated Amazon sign on the exterior of a building at night

If the agency does dig into the One Medical deal at all, there’s a good chance it would start with consumer data concerns.

Photo: Soeren Stache/picture alliance via Getty Images

Amazon is once again in the headlines with a high-value acquisition: This time, it’s reaching a tentacle into the health care space by acquiring boutique primary care provider One Medical for roughly $3.9 billion in cash.

The planned acquisition creates many questions. Some, like “Why health care?” are fairly self-explanatory. Annual U.S. health care spending is measured in trillions of dollars, so it’s no surprise when a business wants a bigger slice of that pie. Amazon has been making direct inroads into health care since acquiring mail-order pharmacy PillPack in 2018, which have only grown as it launched products such as Amazon Pharmacy.

Other questions are slightly more complicated, such as “Is Amazon going to be allowed to do that?” The short answer is almost certainly going to be “yes.” And while that definitely feels weird to some, the long answer has far more to do with how U.S. law handles competition than it does with Amazon.

Isn’t Amazon already under antitrust investigation?

It sure is! The FTC has been probing Amazon since June 2019 at least, and the investigations are reportedly still going strong.

Amazon is also in trouble with Congress. A House committee probing Big Tech issued a blockbuster report in late 2020 accusing Amazon of abusing its “monopoly power,” and saying the company should be split. (Apple, Alphabet and the company now known as Meta also got dinged in that report.) The House Judiciary Committee also recently asked the Justice Department to probe if Amazon had been truthful during the course of the investigation leading to that report.

One of the House staffers who authored that report was Lina Khan, who is now pushing an aggressive antitrust enforcement agenda as the FTC’s chair. Although Amazon is not the only company on the agency’s radar by a long shot, Khan came to national prominence with a 2017 Yale Law Journal article arguing for stronger antitrust enforcement against Amazon. Although the FTC hasn’t filed a suit against Amazon yet, most observers expect the commission to tackle Amazon’s retail practices. The European Commission is likewise investigating if Amazon’s behavior with third-party vendors breaks competition law in the EU.

Amazon’s AWS business, which controls at least a third of the cloud services market, is also reportedly under antitrust scrutiny, and there are lawsuits underway in both Washington state and D.C. alleging Amazon’s behavior around its third-party marketplace vendors violates antitrust law.

So are antitrust regulators going to investigate this deal?

Amazon definitely has to file paperwork about the deal with the FTC, there’s no way around that. Companies planning a merger or acquisition above a certain threshold — $101 million for 2022 — must file their plans with the FTC before completing the transaction. That filing kicks off a 30-day waiting period that regulators can resolve one of three ways: They can grant early termination, meaning they have no issues with the transaction; they can file a second request for information, kicking off an actual probe; or they can do nothing at all, and simply let the waiting period expire.

That “second request” is basically where a formality turns into an investigation. There’s no guarantee the FTC would open one, but for a transaction that both involves Amazon and is valued at more than $1 billion, there’s definitely a non-zero chance it would.

We saw something similar last year when Amazon acquired MGM Studios. The transaction kicked off a flurry of investigation and calls for stronger antitrust enforcement — but when you get right down to it, “film studio” is not Amazon’s core business, nor is it anything like the largest player in the space, and so regulators worldwide more or less said, “ugh, OK, fine,” and Amazon moved forward as if the FTC had, too.

It’s worth noting, though, that even if the waiting period closes uneventfully, that doesn’t mean the FTC is done with Amazon. Even though the MGM transaction closed uneventfully in the spring, media reports from late May and early June suggest the commission is still deeply probing the transaction.

What would regulators be looking for?

Historically, U.S. antitrust regulators are concerned with intense concentration in a specific, tightly defined market. As an example, let’s say four companies manufacture widgets, and each of those companies has 25% market share. If Widgets Inc. purchases two of its competitors and achieves 75% market share, it gains outsized power and can distort the market around it. The remaining company, holding 25% market share, will have a harder time competing and new competitors will be extremely hard to spin up.

But Amazon, despite its prior efforts in health care, is not a major competitor in the present landscape. Even an extremely determined Amazon foe with an axe to grind would have a hard time making a case that Amazon is dominant in or controls the U.S. health care market, because it doesn’t.

What Amazon does do is put tentacles out into a hundred market segments at once: It’s the biggest U.S. cloud services provider. It’s the biggest U.S. ecommerce site. It’s an Emmy- and Oscar-nominated streaming video service. It’s a surprisingly competitive music streaming service. It’s a high-end supermarket chain. It’s a shipping and logistics company. It’s even a pharmacy.

In short, if antitrust enforcement is usually concerned with the whales that move through the world hoovering up all the food (i.e. smaller companies) in their sight, Amazon is in comparison a giant squid, extending its reach farther away and grasping tightly. And while that might still be deadly if you’re metaphorically swimming nearby, there just isn’t as much of a playbook around for dealing with it.

Where regulators are starting to get concerned, though, is the way Amazon ties its various offerings together. Sometimes bundles can be hugely beneficial to consumers, but depending on how they’re shaped and enforced, they can also be harmful to would-be competitors. In the retail space, for example, the Fulfillment by Amazon program allows shoppers to buy from several disparate third-party merchants easily and at once, but merchants complain Amazon’s terms harm their business financially.

One Medical’s model is membership-based: For a fee of about $200 per year, participants get access to the entire One Medical system and all its features. Basically, it’s streamlined medical care as a service. That business model may sound awfully familiar to Amazon’s more than 160 million U.S. Prime subscribers, who pay $139 per year for access to the full array of Amazon goods and free shipping on those goods.

But when the Prime parent acquires a company that already has a fan base, things change. Amazon has “Amazonified” Whole Foods since acquiring the grocer, for example, and now ties some of its products and benefits to a Prime subscription. Whole Foods customers have not always been happy with the way those services have been integrated, and neither have employees. Some vendors have also had a harder time getting their products onto store shelves and out to consumers than before the acquisition, thanks to Amazon changing Whole Foods’ purchasing structure and leveraging its size to make vendors charge less for their products and cover more costs.

Perhaps more critically, Amazon also ties all the data from its various services and offerings together. And while grocery data is personal, a preference for organic avocados or fresh chocolate chip cookies is not anywhere near as sensitive as the kind of data a primary care practice has available about its patients. While some of that information is explicitly covered by HIPAA, other health care data that technology companies can glean from individuals is not. Several One Medical members immediately aired their concerns about data on Twitter as soon as the transaction was announced.


Although consumer data has not traditionally been something the FTC considers when reviewing a merger, user data is one of the concerns the agency has expressed about Microsoft’s pending acquisition of video game publisher Activision Blizzard. If the agency does dig into the One Medical deal at all, there’s a good chance it would start there.
Fintech

Judge Zia Faruqui is trying to teach you crypto, one ‘SNL’ reference at a time

His decisions on major cryptocurrency cases have quoted "The Big Lebowski," "SNL," and "Dr. Strangelove." That’s because he wants you — yes, you — to read them.

The ways Zia Faruqui (right) has weighed on cases that have come before him can give lawyers clues as to what legal frameworks will pass muster.

Photo: Carolyn Van Houten/The Washington Post via Getty Images

“Cryptocurrency and related software analytics tools are ‘The wave of the future, Dude. One hundred percent electronic.’”

That’s not a quote from "The Big Lebowski" — at least, not directly. It’s a quote from a Washington, D.C., district court memorandum opinion on the role cryptocurrency analytics tools can play in government investigations. The author is Magistrate Judge Zia Faruqui.

Keep Reading Show less
Veronica Irwin

Veronica Irwin (@vronirwin) is a San Francisco-based reporter at Protocol covering fintech. Previously she was at the San Francisco Examiner, covering tech from a hyper-local angle. Before that, her byline was featured in SF Weekly, The Nation, Techworker, Ms. Magazine and The Frisc.

The financial technology transformation is driving competition, creating consumer choice, and shaping the future of finance. Hear from seven fintech leaders who are reshaping the future of finance, and join the inaugural Financial Technology Association Fintech Summit to learn more.

Keep Reading Show less
FTA
The Financial Technology Association (FTA) represents industry leaders shaping the future of finance. We champion the power of technology-centered financial services and advocate for the modernization of financial regulation to support inclusion and responsible innovation.
Enterprise

AWS CEO: The cloud isn’t just about technology

As AWS preps for its annual re:Invent conference, Adam Selipsky talks product strategy, support for hybrid environments, and the value of the cloud in uncertain economic times.

Photo: Noah Berger/Getty Images for Amazon Web Services

AWS is gearing up for re:Invent, its annual cloud computing conference where announcements this year are expected to focus on its end-to-end data strategy and delivering new industry-specific services.

It will be the second re:Invent with CEO Adam Selipsky as leader of the industry’s largest cloud provider after his return last year to AWS from data visualization company Tableau Software.

Keep Reading Show less
Donna Goodison

Donna Goodison (@dgoodison) is Protocol's senior reporter focusing on enterprise infrastructure technology, from the 'Big 3' cloud computing providers to data centers. She previously covered the public cloud at CRN after 15 years as a business reporter for the Boston Herald. Based in Massachusetts, she also has worked as a Boston Globe freelancer, business reporter at the Boston Business Journal and real estate reporter at Banker & Tradesman after toiling at weekly newspapers.

Image: Protocol

We launched Protocol in February 2020 to cover the evolving power center of tech. It is with deep sadness that just under three years later, we are winding down the publication.

As of today, we will not publish any more stories. All of our newsletters, apart from our flagship, Source Code, will no longer be sent. Source Code will be published and sent for the next few weeks, but it will also close down in December.

Keep Reading Show less
Bennett Richardson

Bennett Richardson ( @bennettrich) is the president of Protocol. Prior to joining Protocol in 2019, Bennett was executive director of global strategic partnerships at POLITICO, where he led strategic growth efforts including POLITICO's European expansion in Brussels and POLITICO's creative agency POLITICO Focus during his six years with the company. Prior to POLITICO, Bennett was co-founder and CMO of Hinge, the mobile dating company recently acquired by Match Group. Bennett began his career in digital and social brand marketing working with major brands across tech, energy, and health care at leading marketing and communications agencies including Edelman and GMMB. Bennett is originally from Portland, Maine, and received his bachelor's degree from Colgate University.

Enterprise

Why large enterprises struggle to find suitable platforms for MLops

As companies expand their use of AI beyond running just a few machine learning models, and as larger enterprises go from deploying hundreds of models to thousands and even millions of models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

As companies expand their use of AI beyond running just a few machine learning models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

Photo: artpartner-images via Getty Images

On any given day, Lily AI runs hundreds of machine learning models using computer vision and natural language processing that are customized for its retail and ecommerce clients to make website product recommendations, forecast demand, and plan merchandising. But this spring when the company was in the market for a machine learning operations platform to manage its expanding model roster, it wasn’t easy to find a suitable off-the-shelf system that could handle such a large number of models in deployment while also meeting other criteria.

Some MLops platforms are not well-suited for maintaining even more than 10 machine learning models when it comes to keeping track of data, navigating their user interfaces, or reporting capabilities, Matthew Nokleby, machine learning manager for Lily AI’s product intelligence team, told Protocol earlier this year. “The duct tape starts to show,” he said.

Keep Reading Show less
Kate Kaye

Kate Kaye is an award-winning multimedia reporter digging deep and telling print, digital and audio stories. She covers AI and data for Protocol. Her reporting on AI and tech ethics issues has been published in OneZero, Fast Company, MIT Technology Review, CityLab, Ad Age and Digiday and heard on NPR. Kate is the creator of RedTailMedia.org and is the author of "Campaign '08: A Turning Point for Digital Media," a book about how the 2008 presidential campaigns used digital media and data.

Latest Stories
Bulletins